Patient-Specific Models of Treatment Effects Explain Heterogeneity in Tuberculosis

Ethan Wu,Caleb Ellington,Ben Lengerich,Eric P. Xing

2024-11-16

Abstract:Tuberculosis (TB) is a major global health challenge, and is compounded by co-morbidities such as HIV, diabetes, and anemia, which complicate treatment outcomes and contribute to heterogeneous patient responses. Traditional models of TB often overlook this heterogeneity by focusing on broad, pre-defined patient groups, thereby missing the nuanced effects of individual patient contexts. We propose moving beyond coarse subgroup analyses by using contextualized modeling, a multi-task learning approach that encodes patient context into personalized models of treatment effects, revealing patient-specific treatment benefits. Applied to the TB Portals dataset with multi-modal measurements for over 3,000 TB patients, our model reveals structured interactions between co-morbidities, treatments, and patient outcomes, identifying anemia, age of onset, and HIV as influential for treatment efficacy. By enhancing predictive accuracy in heterogeneous populations and providing patient-specific insights, contextualized models promise to enable new approaches to personalized treatment.

Machine Learning

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is: **How to explain the heterogeneity of tuberculosis (TB) treatment effects through personalized models**. Specifically, the paper aims to overcome the problem that traditional models ignore individual differences when dealing with the TB patient population, thereby improving the accuracy of predicting treatment effects for different patients and providing new methods for personalized treatment.

### Specific background and challenges of the problem

1. **Global health challenges of tuberculosis**:
- Tuberculosis is one of the top ten causes of death globally, and its treatment effect is affected by multiple comorbidities (such as HIV, diabetes, anemia, etc.).
- These comorbidities complicate the treatment results, leading to significant differences in patients' responses to treatment.

2. **Limitations of existing models**:
- Traditional models usually focus on predefined broad patient groups and ignore the subtle differences of individual patients.
- Standardized treatment regimens cannot fully consider the unique situation of each patient, resulting in poor treatment effects.

3. **Multimodality and heterogeneity of data**:
- Existing tuberculosis datasets (such as TB Portals) contain a large amount of multimodal measurement data, including clinical, demographic, and imaging information.
- Processing these highly heterogeneous data requires new modeling methods.

### The method proposed in the paper

To address the above challenges, the paper proposes the method of **Contextualized Machine Learning**, specifically including:

- **Personalized modeling**: Through the multi - task learning method, encode the patient's contextual information into a personalized treatment effect model to reveal the patient - specific treatment benefits.
- **Decompose the treatment effect model**: Decompose the treatment effect model into three parts:
- Context - invariant treatment effect ($\beta$)
- Context - dependent treatment effect ($\beta(C)$)
- Direct effect of context ($\mu(C)$)

### Key formulas

The following key formulas are used in the paper to describe the contextualized model:

\[
\text{logodds}(Y|X, C)=X\beta + X\beta(C)+\mu(C)
\]

where:
- $Y$ represents the patient's outcome (such as survival or death)
- $X$ represents treatment
- $C$ represents context (such as comorbidity, age, occupation, etc.)
- $\beta$ represents the context - invariant treatment effect
- $\beta(C)$ represents the context - dependent treatment effect
- $\mu(C)$ represents the direct effect of context

### Experimental results

By analyzing more than 3,000 tuberculosis patients in the TB Portals dataset, the paper shows the superiority of the contextualized model in predicting treatment effects. The specific results are as follows:

- **Prediction accuracy**: The contextualized model has achieved an accuracy rate of 83.7% in predicting survival/death outcomes, which is significantly better than traditional statistical models and black - box models.
- **Identification of key factors**: It has been found that factors such as anemia, age, and HIV status have a significant impact on treatment effects, especially on the efficacy of certain drugs.

### Conclusion

By introducing the contextualized machine learning method, the paper not only improves the prediction accuracy but also provides new insights for personalized treatment. These findings are of great significance for clinical practice, especially when considering the specific situation of patients in optimizing tuberculosis treatment regimens.